Vaccine Development for Marburg Virus Disease
Marburg virus disease is a serious and often deadly illness caused by a filovirus — the same family that also includes Ebola. With no licensed vaccine currently available, Sabin’s R&D program is advancing a chimpanzee adenovirus type 3 (cAd3) vaccine to protect against this disease threat. Fatality rates for Marburg have ranged from 24 to 88% in past outbreaks. A Phase 2 clinical trial for Sabin’s Marburg vaccine candidate is currently underway.